학술논문
HER2-overexpressing/amplified breast cancer as a testing ground for antibody–drug conjugate drug development in solid tumors
Document Type
Review
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 February 2020, 26(4):775-786)
Subject
Language
English
ISSN
15573265
10780432
10780432